Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2019-2029

Back to Pharma Reports

Global Vaccine Contract Manufacturing Market Report 2019-2029

Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

PUBLISHED: 02 April 2019

PAGES: 217

PRODUCT CODE: PHA0383

SUBMARKET: Biotechnology Contract Services Next Generation Technologies Pharma

SKU: PHA0383 Categories: Biotechnology, Contract Services, Next Generation Technologies, Pharma, Pharma Tags: PHA0383, PHA0415, PHA0418, PHA0440, PHA0453, PHA0456, PHA0732, PHA1149

The global vaccine contract manufacturing market was worth $1.9bn in 2018 and is expected to grow at a CAGR of 9.3% from 2019-2023. In 2018, the paediatric vaccines segment held 48% of the global vaccine contract manufacturing market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 80 tables and 57 figures– all unavailable elsewhere.

The 217-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by type:
• Paediatric Vaccines
• Adult Vaccines
• Influenza Vaccines
• Therapeutic Vaccines

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

• Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan and India
• Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa

The regional markets are further broken down by type and workflow.

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• Evonik Degusa
• IDT Biologika
• Lonza
• Meridian Life Science
• Nipro Corporation
• Pfizer CentreOne
• Sigma Aldrich Fine Chemicals
• SynCo Bio Partners
• Vetter Pharmaceutical

• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2018?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2019 to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029?
• How will the industry evolve during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Analysis : Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview

1.1 World Vaccine Contract Manufacturing Market Highlights

1.2 Why You Should Read This Report?

1.3 How This Report Delivers

1.4 Key Questions Answered by This Analytical Report

1.5 Who is This Report For?

1.6 Methodology

1.7 Associated Visiongain Reports

1.8 Frequently Asked Questions (FAQ)

2. Introduction to Vaccines

2.1 The History of Vaccines

2.2 How Do Vaccines Work?

2.2.1 Artificial Immunity

2.3 Types of Vaccine

2.3.1 Live, Attenuated Vaccines (LAVs)

2.3.2 Recombinant Live Vaccines

2.3.3 Inactivated Vaccines

2.3.4 Toxoid Vaccines

2.3.5 Subunit Vaccines

2.3.6 Conjugate Vaccines

2.3.7 Recombinant Subunit Vaccines

2.3.8 DNA Vaccines

2.3.9 Recombinant Vector Vaccines

2.3.10 Therapeutic Vaccines

2.4 Diseases Preventable with Vaccines

2.5 The Rise of the Vaccines Market

2.6 Technological and Regulatory Improvements

3. Vaccine Manufacturing Technologies, 2018

3.1 Summary of Vaccine Technology Trends

3.2 New Substrates for Vaccine Production

3.2.1 Shift towards Cell-Based Manufacturing Technology

3.2.2 Benefits of Cell-Based Techniques

3.2.3 Mammalian Cell Lines

3.2.3.1 Madin Darby Canine Kidney Cells (MDCK)

3.2.3.2 Vero Cells

3.2.3.3 PerC6 Cells

3.2.4 Avian-Derived Cell Lines

3.2.4.1 EB66 Stem Cell Technology: Vivalis

3.2.5 Plant-Based Vaccines

3.2.5.1 Medicago’s Proficia VLP Vaccine Technology

3.2.6 Insect Egg-Based Production Systems

3.2.6.1 Novavax

3.2.6.2 Protein Sciences Corporation (PSC)

3.3 Next-Generation Expression Systems and Vectors: Increasing Production Yield

3.3.1 AdVac Technology: Crucell

3.3.2 AdCEV Vectors: AfriVax

3.3.3 Pfenex Expression Technology: Pfenex

3.4 Equipment Trends

3.4.1 The Shift Towards Disposable Single-use Equipment

3.4.2 Bioreactors and Vaccine Production

3.4.2.1 Single-Use Bioreactors

3.4.2.2 Main Applications of Disposable Bioreactors

3.4.2.3 Current Single-Use Bioreactor Systems in the Market

3.5 Prefilled Syringes and Vaccines

3.5.1 Growing Market for Pre-Filled Syringes

3.5.2 Pre-Filled Vaccine Products

3.5.3 Drivers and Restraints for Pre-Filled Syringes

3.5.4 Product Stability and Quality Assurance Programme

3.5.4.1 Paediatric H1N1 Vaccine

3.5.4.2 Reported Challenges Flu Vaccines

3.5.4.3 Novartis' Agriflu and Fluad Ban is Lifted

3.5.4.4 Baxter Flu Vaccine and Side Effects

3.5.4.5 Reported Shelf Life with H1N1 Vaccine

3.6 Lyophilisation and Vaccine Manufacturing

3.6.1 Lyophilisation of Vaccines Will Increase

3.7 Cell Media Can Improve Virus Yield

4. The Global Vaccine Manufacturing Market 2019-2029

4.1 Overview of the Global Vaccine Manufacturing Market 2019-2029

4.2 World Vaccine Market Forecast 2019-2029

4.3 The Global Vaccine Market by Submarket, 2018 and 2019

4.4 Growth in Vaccine Market Will Drive Efficiency in Vaccine Manufacturing

4.5 Paediatric Vaccines Market Overview

4.6 Adult Prophylactic Vaccines Market Overview

4.7 Influenza Vaccines Market Overview

4.8 Therapeutic Vaccines Market Overview

5. The Global Vaccine Contract Manufacturing 2019-2029

5.1 Outsourcing in the Pharmaceutical and Biotechnology Industry

5.1.1 Reasons to Outsource

5.1.2 Benefits of Outsourcing

5.1.3 The Challenges in Outsourcing Vaccine Manufacturing

5.1.4 Why Should Companies Outsource Vaccine Manufacturing?

5.1.5 Strategic Outsourcing Vs Tactical Outsourcing

5.1.6 Virtual Companies

5.2 Contract Manufacturing Organisations (CMOs)

5.2.1 Manufacturing Services Offered by CMOs

5.2.2 Vaccine Manufacturing Activities Typically Outsourced

5.3 The Vaccine Contract Manufacturing Market: Overall Revenue Forecast 2019-2029

5.4 Contract Manufacturing Market for Vaccines 2018-2029

5.4.1 Market Size for Contract Manufacturing of Vaccines 2018

5.4.2 Vaccine Contract Manufacturing Market Forecast 2019-2029

6. Vaccine Contract Manufacturing Market by Vaccine Type, 2019-2029

6.1 Paediatric Vaccines

6.2 Adult Vaccines

6.3 Influenza Vaccines

6.4 Therapeutic Vaccines

7. Vaccine Contract Manufacturing Market by Workflow, 2019-2029

7.1 Downstream Processing

7.1.1 Fill & Finish Operations

7.1.2 Analytical & QC Studies

7.1.3 Packaging

7.2 Upstream Processing

7.2.1 Mammalian Expression Systems

7.2.2 Bacterial Expression Systems

7.2.3 Yeast Expression Systems

7.2.4 Baculovirus/Insect Expression Systems

7.2.5 Other Upstream Processing

8. Leading National Markets for Vaccine Contract Manufacturing, 2019-2029

8.1 Leading National Markets for Vaccine Contract Manufacturing

8.2 North America Vaccine Contract Manufacturing Market, 2018-2029

8.2.1 US Vaccine Contract Manufacturing Market Forecast, 2018-2029

8.2.2 Canada Vaccine Contract Manufacturing Market Forecast, 2018-2029

8.3 The Europe Vaccine Contract Manufacturing Market, 2018-2029

8.3.1 Germany Vaccine Contract Manufacturing Market, 2016-2028

8.3.2 UK Vaccine Contract Manufacturing Market, 2018-2029

8.3.3 French Vaccine Contract Manufacturing Market, 2018-2029

8.3.4 Italy Vaccine Contract Manufacturing Market, 2018-2029

8.3.5 Spain Vaccine Contract Manufacturing Market, 2018-2029

8.4 Asia-Pacific Vaccine Contract Manufacturing Market, 2018-2029

8.4.1 Japan Vaccine Contract Manufacturing Market, 2018-2029

8.4.2 China Vaccine Contract Manufacturing Market, 2018-2029

8.4.3 India Vaccine Contract Manufacturing Market, 2018-2029

8.5 Rest of the World Vaccine Contract Manufacturing Market, 2018-2029

8.5.1 Brazil Vaccine Contract Manufacturing Market, 2018-2029

8.5.2 Mexico Vaccine Contract Manufacturing Market, 2018-2029

8.5.3 Russia Vaccine Contract Manufacturing Market, 2018-2029

8.5.4 South Africa Vaccine Contract Manufacturing Market, 2019-2029

9. Leading Vaccine Contract Manufacturing Companies, 2018-2029

9.1 Leading Vaccine Contract Manufacturing Organisations

9.2 Baxter BioPharma Solutions

9.2.1 Recent Financial Performance

9.2.2 Key Developments

9.3 Boehringer Ingelheim

9.3.1 Recent Financial Performance

9.3.2 Ben Venue Laboratories

9.3.3 Manufacturing Deals 2011-2017

9.4 Catalent

9.4.1 Recent Financial Performance

9.4.2 Catalent: Financial Performance by Segment, 2011-2016

9.4.3 Catalent Injectable Vaccines

9.4.4 Catalent: Zydis Technology

9.4.5 Regional Market Expansion Strategy

9.5 Charles River Laboratories

9.5.1 Recent Financial Performance, 2011-2017

9.5.2 Financial Performance by Segment, 2012-2018

9.5.3 Vaccine Manufacturing Services

9.5.4 Charles River Avian Vaccine Services

9.5.5 Vaccine Manufacturing Expansion

9.5.6 Outlook and Early Stage Restructuring

9.5.7 Partnerships

9.5.7.1 Partnership with AstraZeneca

9.5.7.2 Partnership with Batavia

9.6 IDT Biologika GmbH

9.7 Lonza

9.7.1 Recent Financial Performance

9.7.2 Manufacturing Division Restructuring

9.8 Meridian Life Science

9.8.1 Recent Financial Performance, 2012-2018

9.9 Sigma-Aldrich Fine Chemicals (SAFC) (Merck KGaA)

9.10 SynCo Bio Partners

9.10.1 Recent Developments

9.10.1.1 Expansion of Facilities

9.10.1.2 FDA Approval of Partner Application

9.11 AbbVie Contract Manufacturing

9.11.1 AbbVie Offers Full-Service Contract Manufacturing

9.11.2 Recent Financial Performance: Revenue 2012-2017

9.11.3 Strategic Developments 2017-2018

9.12 Evonik Degussa

9.12.1 API and Drug Delivery Services

9.13 Vetter Pharmaceutical

9.13.1 Financial Performance, 2013-2017

9.13.2 Regional Expansion

9.14 Pfizer CentreOne

9.14.1 Financial Performance, 2013-2018

9.14.2 Strategic Developments 2017-2018

9.15 Nipro Corporation

9.15.1 Contract Manufacturing Capabilities

10. Global Vaccine Contract Manufacturing Market: World Market Trends 2018-2029

10.1 Vaccine Contract Manufacturing Industry Trends

10.2 Strengths

10.2.1 Many Companies Cannot Afford In-house Capabilities

10.2.2 Outsourcing Improves Time to Market

10.2.3 Manufacturers Get Access to Specialised Technologies

10.2.4 Shift Towards Emerging Markets as Favourable Outsourcing Destinations

10.3 Weaknesses

10.3.1 Mass Vaccine Manufacturing Kept In-house

10.3.2 A Highly-Fragmented Vaccine Contract Manufacturing Market

10.3.3 An Unpredictable Supply and Demand Business Model

10.4 Opportunities

10.4.1 Many Vaccines in the Product Pipeline

10.4.2 Emerging Market’s Growing Demand for Vaccines

10.4.2.1 Dynamic Change: Emerging Markets are Major Vaccine Developers

10.4.3 Changing World Demographics

10.5 Threats

10.5.1 Post Recession: Biotech Suffer from Severe Cuts in Capital Funding

10.5.2 The Public are Slow to Accept Novel Technologies

10.5.3 Perception of Risk by the Original Vaccine Manufacturers

11. Conclusion

11.1 Overview

11.2 Regulatory and Quality Standards Create High Barriers of Entry

11.3 Emerging Markets Will Show Stronger Growth

Appendices

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Tables

Table 2.1 Timeline of Key Events in Vaccine Development, c.1000 AD – Present

Table 3.1 Vaccine Development Pipeline Using Crucell’s AdVac Technology

Table 3.2 Benefits and Drawbacks of Using Disposable Technology for Vaccine Production

Table 3.3 Companies Providing Disposable Biomanufacturing Platforms/Systems

Table 3.4 Some Leading Pre-Filled Syringe Vaccine Products

Table 3.5 Prominent Lyophilised Vaccines

Table 3.6 Examples of Serum-Free Media for Vaccine Manufacturing

Table 4.1 The Global Vaccine Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) 2018-2029

Table 4.2 The Global Vaccine Market: Revenue ($bn) and Market Share by Submarket (%), 2018-2019

Table 5.1 The Global Vaccine Contract Manufacturing Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 6.1 Global Paediatric Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 6.2 Global Adult Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 6.3 Global Influenza Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 6.4 Global Therapeutic Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.1 Global Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.2 Global Fill & Finish Operations Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.3 Global Analytical & QC Studies Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.4 Global Packaging Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.5 Global Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.6 Global Mammalian Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.7 Global Bacterial Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.8 Global Yeast Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.9 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 7.10 Global Other Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.1 Leading National Vaccine Contract Manufacturing Markets Forecast: Revenue ($m) and Market Share (%), 2018-2019

Table 8.2 North America Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.3 North America Vaccine Contract Manufacturing Market, By Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.4 North America Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.5 North America Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.6 North America Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.7 US Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.8 Canada Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.9 Europe Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.10 Europe Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.11 Europe Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.12 Europe Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.13 Europe Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.14 Germany Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.15 UK Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.16 France Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.17 Italy Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.18 Spain Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.19 Asia-Pacific Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.20 Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.21 Asia-Pacific Vaccine Contract Manufacturing Marke by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.22 Asia Pacific Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.23 Asia Pacific Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.24 Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.25 Chinese Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.26 Indian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.27 RoW Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.28 RoW Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.29 RoW Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.30 RoW Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.31 RoW Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.32 Brazilian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.33 Mexican Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.34 Russian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 8.35 South Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029

Table 9.1 Baxter BioPharma Solutions Overview

Table 9.2 Baxter BioPharma Manufacturing: Revenue ($m), Annual Growth (%), CAGR (%), 2013-2018

Table 9.3 Boehringer Ingelheim Biopharmaceuticals Overview

Table 9.4 Boehringer Ingelheim: Biopharmaceuticals Revenue ($m) and Annual Growth Rate (%), 2012-2018

Table 9.5 Catalent Overview

Table 9.6 Catalent: Revenue($m) and AGR (%), 2012-2018

Table 9.7 Charles River Laboratories: Revenue ($m) and AGR (%), 2012-2018

Table 9.8 Charles River Laboratories: Newly Revised Reportable Segments

Table 9.9 Charles River Laboratories: cGMP Vaccine Manufacturing and Testing Capabilities

Table 9.10 Lonza Custom Manufacturing: Revenue ($m) and AGR (%), 2010-2016

Table 9.11 Meridian Bioscience: Revenue ($m), AGR (%), 2012-2018

Table 9.12 SynCo Bio Partners Capabilities

Table 9.13 AbbVie Contract Manufacturing: Details, 2017

Table 9.14 Evonik Degussa Details, 2018

Table 9.15 Vetter Details, 2017

Table 9.16 Vetter Pharmaceutical Manufacturing: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2013-2017

Table 9.17 Pfizer CentreOne Details, 2018

Table 9.18 Pfizer CentreSource: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2013-2018

Table 9.19 Nipro Pharma Overview

Table 9.20 Nipro Pharmaceutical Contract Manufacturing Capabilities: 2011-2017

Table 10.1 SWOT Analysis of the Vaccine Contract Manufacturing Market

List of Figures

Figure 3.1 Influenza Vaccine Production Using a Cell-Based Manufacturing Method

Figure 3.2 Medicago’s Product Pipeline

Figure 3.3 Novavax’ Insect Egg-Based Vaccine Production Process

Figure 3.4 Pre-filled Syringes Market: Drivers and Restraints, 2019-2029

Figure 4.1 The Global Vaccine Market Forecast: Revenue ($bn), AGR (%) 2018-2029

Figure 4.2 The Global Vaccine Market: Market Share by Submarket (%), 2018

Figure 5.1 Selected Tasks Outsourced in the Pharmaceutical and Biotech Industry

Figure 5.2 Global Vaccine Contract Manufacturing Forecast: Revenue ($m), 2019, 2023 and 2029

Figure 5.3 The Global Vaccine Contract Manufacturing Forecast: Revenue ($Mn) and AGR (%), 2018-2029

Figure 6.1 Global Vaccine Contract Manufacturing Forecast by Vaccine Type: Revenue ($m), 2018-2029

Figure 6.2 Global Vaccine Contract Manufacturing Forecast by Vaccine Type: Market Share (%), 2018-2029

Figure 6.3 Global Paediatric Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 6.4 Global Adult Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 6.5 Global Influenza Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 6.6 Global Therapeutic Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.1 Global Vaccine Contract Manufacturing Forecast by Workflow: Revenue ($m), 2018-2029

Figure 7.2 Global Vaccine Contract Manufacturing Forecast, By Workflow: Market Share (%), 2018-2029

Figure 7.3 Global Downstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.4 Global Fill & Finish Operations Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.5 Global Analytical & QC Studies Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.6 Global Packaging Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.7 Global Upstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.8 Global Mammalian Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.9 Global Bacterial Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.10 Global Yeast Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.11 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 7.12 Global Other Upstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.1The Leading National Vaccine Contract Manufacturing: Market Share (%) by Region, 2018

Figure 8.2 North America Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029

Figure 8.3 U.S. Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.4 Canada Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.5 Europe Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029

Figure 8.6 Germany Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.7 UK Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.8 France Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.9 Italy Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.10 Spain Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.11 Asia-Pacific Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029

Figure 8.12 Japanese Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.13 Chinese Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.14 Indian Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.15 RoW Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029

Figure 8.16 Brazilian Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.17 Mexican Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.18 Russia Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 8.19 South Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029

Figure 9.1 Baxter BioPharma Manufacturing: Revenue ($m), 2013-2018

Figure 9.2 Boehringer Ingelheim: Biopharmaceuticals Revenue ($m) and Annual Growth Rate (%), 2012-2018

Figure 9.3 Catalent: Revenue ($m) and AGR (%), 2012-2018

Figure 9.4 Catalent Financial Performance by Division: Revenue ($m), 2013-2018

Figure 9.5 Charles River Laboratories: Revenue ($m) and AGR (%), 2012-2018

Figure 9.6 Lonza Custom Manufacturing: Revenue ($m) and AGR (%), 2010-2016

Figure 9.7 Meridian Bioscience: Revenue ($m), and AGR (%), 2012-2018

Figure 9.8 Nipro Pharmaceutical Contract Manufacturing Capabilities: Orally Administered Drugs, Injectables, External Preparations, 2011-2017

Figure 10.1 Drivers and Restraints for the Vaccine Contract Manufacturing Sector

Figure 11.1 The Global Vaccine Contract Manufacturing Market: Market Share by Region (%), 2018, 2023, 2029

Figure 11.2 The Global Vaccine Contract Manufacturing: National Market Share (%), 2018 – 2029

AbbVie

Accugenix

AfriVax

Alkion Biopharma SAS

AmProtein

Antigenics, Inc.

Arabio

Argenta

Artelis

Astrazeneca

ATM Life Sciences

ATMI

Bacteriological Institute of the Anhaltian Administrative Areas

Batavia Bioservices

Baxter BioPharma

Berna Biotech

Bharat Biotech International Limited

Binnopharm

BioFocus

Biovest

Boehringer Ingelheim

Bristol-Myers Squibb Company

Cadila Pharmaceuticals

Calico

Catalent

Cellexus Limited

Charles River Laboratories

Chemisch-Pharmazeutisches Laboratorium Ravensburg

Colorcon

Crucell

CSL Biotherapies

Daiichi Sankyo Co. Ltd.

Elanco

Eli Lilly

Evonik Degussa

FiberCell

Gallant Custom Laboratories

GE Healthcare

GE Wave Biotech

GlaxoSmithKline Biologics

GSAL

GlaxoSmithKline (GSK)

Hikma

Hyclone

IDT Biologika GmbH

Intercell Corporation

Invitrogen

Irvine Scientific

Janssen Biotech, Inc. (Janssen)

Klocke Group

Kuhner

LG Life Sciences

Lonza

Medicago

Meissner Filtration

Merck & Company

Merck Millipore

Meridian Bioscience

Meridian Life Science

MGC Pharma Co.

Millipore

Mitsubishi Tanabe Pharma

MorphoSys

Mosquirix

MP Biomedicals

Mylan

Neurocrine Biosciences

Nipro Corporation

Novartis

Novartis Vaccines and Diagnostics

Novavax

Organon Teknika Corporation

Pall Life Sciences

PATH

Patheon

Pfizer

Pharmaceutical Base Development Co., Ltd.

Pharmacyclics LLC

Philip Morris International

Pierre-Guerin Biolafitte

Protein Sciences Corporation

Refine Technology

Samsung Bioepis

Sanofi

Sanofi Pasteur

Sartorius Stedim Biotech

Scripps Research

Shanghai Zhangjiang Biotech

ShangPharma Corporation

Sigma Aldrich

Sigma-Aldrich Fine Chemicals

SynCo Bio Partners

SynCo Bio Partners (SynCo)

Thermo Fisher

Vetter Pharmaceutical

Vivalis

Voyager Therapeutics, Inc.

Wave Biotech (GE Healthcare Life Sciences)

Wynca

Xcellerex (GE Healthcare Life Sciences)

ZellWerk

Zhejiang Jiang Yuan Tang Biotechnology Corporation

List of Organizations Mentioned in the Report

Centers for Disease Control and Prevention (CDC)

Defense Advanced Research Projects Agency (DARPA)

European Medicine Agency (EMA)

Food and Drug Administration (FDA)

Institute Pasteur in Paris

Japanese Ministry of Health, Labour and Welfare (MHLW)

National Institute of Allergy and Infectious Diseases (NIAID)

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Bioreactors Market Report 2023-2033

The global Bioreactors market was estimated to be valued at US$9,977.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

29 September 2023

READ

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

27 September 2023

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

25 September 2023

READ

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023

READ

Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2019-2029

Back to Pharma Reports

Global Vaccine Contract Manufacturing Market Report 2019-2029

Download sample pages

Related reports

Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Cell-Based Assays World Industry and Market 2018-2028

Lyophilization in Pharmaceutical Market Forecast 2019-2029

Pharma Leader Series: Top 26 Asthma & COPD Companies 2020-2030

Vaccine Sales Market Forecast 2018-2028

Indian Pharmaceutical Market Forecast 2019-2029

Drug Delivery Technologies Market Forecast 2019-2029

Biologics Market Trends and Forecasts 2018-2028

Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029

Global Biosimilar Monoclonal Antibodies Forecast 2018-2028

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Bioreactors Market Report 2023-2033

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

Our Clients